Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
about
Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease ProgressionBlood transfusion safety in Africa: a literature review of infectious disease and organizational challengesCo-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan AfricansCytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South AfricaEBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.[Molecular tests in diagnosis of Cytomegalovirus (CMV), human herpesvirus 6 (HHV-6) and Epstein-Barr virus (EBV) using real-time PCR in HIV positive and HIV-negative pregnant women in Ouagadougou, Burkina Faso].Viral ocular manifestations: a broad overview.Cancer incidence in Ghana, 2012: evidence from a population-based cancer registryHigh seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa.An antisense transcript in the human cytomegalovirus UL87 gene region.Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South AfricaLow-cost periodontal therapy.A large-scale seroprevalence of Epstein-Barr virus in Taiwan.Comparison of Real-time PCR to ELISA for the detection of human cytomegalovirus infection in renal transplant patients in the Sudan.Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection.Prevalence and dynamics of cytomegalovirus infection among patients undergoing chronic hemodialysisPrevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa[Seroprevalence of human herpes virus-8 in HIV-positive patients at the General Hospital of Yaounde - Cameroon].Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural MalawiSociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey.Polymerase chain reaction to search for Herpes viruses in uveitic and healthy eyes: a South African perspective.Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adultsHuman cytomegalovirus (CMV) in Africa: a neglected but important pathogenAnogenital Lesions: Kaposi's Sarcoma and Its Mimicks.Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West AfricaSeroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in CameroonMolecular diagnostic of cytomegalovirus, Epstein Barr virus and Herpes virus 6 infections among blood donors by multiplex real-time PCR in Ouagadougou, Burkina Faso.Challenges for paediatric transplantation in Africa.Antenatal screening for Toxoplasma gondii, Cytomegalovirus, rubella and Treponema pallidum infections in northern Benin.Review of cytomegalovirus coinfection in HIV-infected individuals in Africa.EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.High Prevalence of Human Herpesvirus 8 Infection in Diabetes Type 2 Patients and Detection of a New Virus Subtype.Seroepidemiology of cytomegalovirus infections in Croatia.Human herpesvirus 8 seroconversion in a population-based cohort of men in Tobago.Prevalence of Human Herpesvirus-8 (HHV-8) in untreated patients with early stage Mycosis Fungoides (A retrospective study).Oral and genital human herpesvirus 8 and human papillomavirus in heterosexual partners.Intrahost genetic variability of human herpes virus-8.Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.
P2860
Q26751304-B2141D0B-3DD3-4BD5-A96D-8038C63A83F9Q26866294-AF83B716-CD1D-4879-A23B-AE67C51F3149Q28534758-98EE3F68-80BE-468A-B693-23F0642AC840Q28743974-9610A914-394E-4721-866E-707A518D6E65Q30390920-35938852-3C61-43F9-8723-09329FDDC5C5Q30394732-85B80D4F-B276-4442-9737-9863A12E5ADEQ30432358-D077E3B6-BB9A-4E08-A449-C3DDE3E610B3Q33712935-4FFC1CE1-9627-48DA-949F-1AC3569B35D7Q33734155-83B5B759-DC3A-4B0C-8725-D2AB8D0479B4Q34072126-461E0FA6-7866-4D61-B0F8-026091B3E055Q34137492-65462A45-F5CA-4BF3-9269-791952C9807AQ34295136-A30B4300-5D5E-4195-9D1B-4C12717A43CBQ35007123-A7BA095A-7EAC-4C02-963B-3E5A165A74EEQ35038604-C36C362F-4A44-4B03-BBA3-880475C43902Q35171944-55E15F60-061F-4D6C-8A3C-37CBA7757A7FQ35232999-B92C1A38-D449-4010-A8D0-F5460CC6EF9FQ35632074-1A9C0185-1A10-48DB-8CA4-EC5018846E4FQ35668284-9F7D77C8-5CE5-407E-B32F-0FE42690FEB9Q35668862-B4A2CA3B-D5F9-48B7-B6FE-CEF0681E432DQ36172022-F8A45234-4107-426E-B51F-1429EFA71F60Q36612814-0064B548-DFBF-414B-B508-0315325A189CQ37015398-2D989694-D2DC-467D-9395-427435097C54Q37141399-A33D0FE1-0E25-494E-9986-F4FE91A42CFEQ37156859-C9BEC7CA-FCD2-4D3C-AC72-B680D9AD66D2Q37208916-36E796FE-7753-43A0-89FB-096B723BAFA4Q37235307-5B01DCA5-26C6-405D-A469-42B35FF7C051Q37608214-AE43FC2D-13C7-4091-94A8-DC9BE623BE39Q38239455-9C8CF551-65A1-483D-987E-3481BC3E6A8EQ38966708-D11601C7-2338-4D68-AAC1-48F4213716BEQ38974815-C0061F33-3975-4CA0-BC79-BB426A220C4DQ40046306-D2963F1F-F28C-4FA9-A1A8-2DA352446E3FQ40444559-D4A7CDF7-487C-40E0-B12F-52F1158EB6B7Q40550243-56461ED2-E13F-4FDD-B88A-74EE9E6C7BD7Q41527934-36A11E55-A944-4D1D-80C6-E4813722B7E7Q42708231-B4732DF1-D889-4422-AF94-5BD1E164709AQ44008140-BFCFCFC6-7D98-4624-8218-87310FF04757Q44680813-CD9826D0-1C6B-4590-8A3A-6A2E96EF94A6Q45323519-F1CD67F5-4318-488D-B5A4-F32DAB1126D4Q47127822-E2AC90F0-D31E-4C52-B1B3-14D136029ABEQ55312268-F24FA539-A386-4A75-9D86-47E276664FDB
P2860
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@ast
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@en
type
label
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@ast
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@en
prefLabel
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@ast
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@en
P2093
P2860
P921
P356
P1476
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.
@en
P2093
Andrew A Adjei
Clement Adu-Gyamfi
Foster Gbagbo
Henry B Armah
Isaac Asare
Isaac Boamah
P2860
P2888
P356
10.1186/1471-2334-8-111
P577
2008-08-18T00:00:00Z
P5875
P6179
1049105621